The Property Changes of Urine Crystallites of Calcium Oxalate Stone Formers before and after Taking Medicine

被引:2
作者
Li Jun-jun [1 ]
Hou Shan-hua [1 ]
Xia Zhi-yue [1 ]
Ouyang Jian-ming [1 ]
机构
[1] Jinan Univ, Inst Biomineralizat & Lithiasis Res, Guangzhou 510632, Guangdong, Peoples R China
关键词
Urine crystallites; Calcium oxalate; Zeta potential; Particle size distribution; XRD; FTIR;
D O I
10.3964/j.issn.1000-0593(2011)08-2263-05
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
The property changes of urine crystallites of six cases of calcium oxalate stone formers before and after taking medicine were comparatively studied using X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy, nanoparticle size analyzer, and transmission electron microscopy (TEM). The results showed that the urinary pH increases after taking medicine (before taking 5.87 +/- 0.51, after taking 6.23 +/- 0.74.) Before taking medicine the main components of urine crystallites were uric acid, calcium oxalate monohydrate (COM) and biphosphate. The types and quantities of urine crystallites after taking medicine were less than that of before. The average size of urine crystallite before taking medicine was (579 +/- 326) nm, and it reduced to (404 +/- 338) nm after taking medicine. After taking medicine the zeta potential was also decreased to (-7.29 +/- 4.16) mV from (-4.28 +/- 2.55) mV. The decrease in zeta potential is beneficial to preventing urinary crystallites deposition. The edges and corners of urine crystallite were sharp with significant aggregation before taking medicine, while they became blunt and less aggregation after taking medicine. The analysis of the property changes of urine crystallites of calcium oxalate stone patients before and after taking medicine by using modern equipments has important clinical significance to the clinical prevention and treatment of urinary stones.
引用
收藏
页码:2263 / 2267
页数:5
相关论文
共 14 条
[1]   Microhardness and acoustic behavior of calcium oxalate monohydrate urinary stone [J].
Ali, A. Mohamed ;
Raj, N. Arunai Nambi ;
Kalainathan, S. ;
Palanichamy, P. .
MATERIALS LETTERS, 2008, 62 (16) :2351-2354
[3]   Infrared analysis of urinary stones, using a single reflection accessory and a KBr pellet transmission [J].
Benramdane, L. ;
Bouatia, M. ;
Idrissi, M. O. B. ;
Draoui, M. .
SPECTROSCOPY LETTERS, 2008, 41 (02) :72-80
[4]  
CHEN Yun-kui, 1993, INFRARED ABSORPTION, P122
[5]   Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones [J].
Chow, K ;
Dixon, J ;
Gilpin, S ;
Kavanagh, JP ;
Rao, PN .
KIDNEY INTERNATIONAL, 2004, 65 (05) :1724-1730
[6]  
Fazil M Y M, 2009, UROL RES, V37, P283
[7]   Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers [J].
Fuselier, HA ;
Moore, K ;
Lindberg, J ;
Husserl, FE ;
Cole, FE ;
Kok, DJ ;
Whitehead, D ;
Galliano, DJ ;
Erwin, DT .
UROLOGY, 1998, 52 (06) :988-994
[8]   CITRATE AND CALCIUM EFFECTS ON TAMM-HORSFALL GLYCOPROTEIN AS A MODIFIER OF CALCIUM-OXALATE CRYSTAL AGGREGATION [J].
HESS, B ;
ZIPPERLE, L ;
JAEGER, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (06) :F784-F791
[9]  
JIN Yong, 2008, XRAY DIFFRACTION ANA, P192
[10]  
King M., 1992, Powder diffraction file alphabetic index, inorganic phases/ organic phases